Open tender · Germany · Pharmaceutical products
Open house Arzneimittelrabattverträge Certolizumab pegol, ATC L04AB05
In EnglishOpen house for drug discount agreements Certolizumab pegol, ATC L04AB05
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house for drug discount agreements Certolizumab pegol, ATC L04AB05”. Bids close on 5 April 2027, 12:00 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
The AOK Bayern intends to conclude non-exclusive discount agreements for the active substance Certolizumab pegol (ATC L04AB05) with all interested pharmaceutical companies that meet the eligibility requirements.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 6 requirements to qualify (1 on experience, 5 certifications and registrations) and the 3 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences